Clinicopathological characteristics and eligibility for adjuvant olaparib of germline BRCA1/2 mutation carriers with HER2-negative early breast cancer
携带 BRCA1/2 胚系突变且 HER2 阴性早期乳腺癌患者的临床病理特征及辅助奥拉帕尼治疗的适用性
期刊:NPJ Breast Cancer
影响因子:7.6
doi:10.1038/s41523-024-00632-8
Morganti, Stefania; Jin, Qingchun; Vincuilla, Julie; Buehler, Ryan; Ryan, Sean; Stokes, Samantha; Parker, Tonia; Mittendorf, Elizabeth A; King, Tari A; Weiss, Anna; Partridge, Ann H; Bychkovsky, Brittany L; Curigliano, Giuseppe; Tayob, Nabihah; Lin, Nancy U; Garber, Judy E; Tolaney, Sara M; Lynce, Filipa
